Welcome to our dedicated page for Privia Health Group SEC filings (Ticker: PRVA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Pinpointing payer-mix risks, capitated revenue shifts, or physician-count growth inside Privia Health鈥檚 SEC reports can feel like decoding medical jargon. The company鈥檚 value-based care contracts, risk-sharing models, and reimbursement disclosures span hundreds of pages鈥攎eaning critical insights are easy to miss.
Stock Titan鈥檚 AI-powered engine turns that complexity into clarity. Need the latest Privia Health quarterly earnings report 10-Q filing or an alert the moment a doctor-led executive sells shares? Our platform streams every Form straight from EDGAR, then delivers plain-English explanations. From Privia Health insider trading Form 4 transactions to a Privia Health 8-K material events explained summary, you鈥檒l see what moved the stock and why鈥攚ithout wading through dense text.
Here鈥檚 what you can accomplish in minutes:
- Track Privia Health Form 4 insider transactions real-time and monitor physician-executive buying trends.
- Dive into a Privia Health annual report 10-K simplified view that surfaces capitated revenue percentages, CMS dependence, and segment margins.
- Receive concise Privia Health earnings report filing analysis that links revenue swings to patient-panel growth.
- Compare incentive structures through the Privia Health proxy statement executive compensation breakdown.
Whether you鈥檙e understanding Privia Health SEC documents with AI for the first time or need quick context before a trade, our real-time updates and expert notes keep you ahead. Complex disclosures, now clear.
Privia Health Group, Inc. Schedule 13G discloses that a Rubicon-linked group holds a material passive stake in the company's common stock. The Reporting Persons beneficially own 6,278,522 shares, representing 5.14% of the outstanding class based on the issuer's reported total of 122,673,254 shares. All voting and dispositive power over these shares is reported as shared (no sole voting or dispositive power). The shares are held through Puma Growth Holdings, LLC, with a clear chain of control: Puma owns the shares, RF OP GP acts as manager, RF OP GP 2 is the general partner of RF OP GP, and Rubicon Founders is the ultimate member; Adam Boehler is identified among the Reporting Persons. The filing is submitted on Schedule 13G and includes a certification that the stake is not held to influence control of the issuer.
Privia Health Group (PRVA) posted solid top-line growth in Q2 2025. Revenue rose 23.4 % to $521.2 million, driven by stronger Value-Based Care (capitated +34 % to $75.5 million; shared-savings +51 % to $60.0 million) and fee-for-service patient care of $331.5 million. Six-month revenue reached $1.00 billion, up 19.5 % year-over-year. Gross profit improved 14.8 % to $112.8 million.
Earnings moderated. Operating income fell to $3.3 million (-34.6 %), and net income attributable to PRVA slipped to $2.7 million (EPS basic $0.02 vs. $0.03). YTD net income rose 7.1 % to $6.9 million on better first-quarter results.
Cash deployment and balance sheet. The company closed a 51 % acquisition of Privia Medical Group Arizona for $89.1 million cash, lifting goodwill to $172.2 million and intangibles to $170.1 million. Cash & equivalents declined to $390.1 million from $491.1 million at year-end, reflecting the deal and a $16.1 million operating cash outflow. No borrowings are outstanding on the $125 million revolver; total debt remains zero. Stockholders鈥� equity increased to $733.5 million on share issuance and retained earnings.
Key operating metrics. Implemented providers grew 13.8 % to 5,125, and attributed lives rose 15.2 % to 1.38 million. Practice collections reached $862.9 million (+18.5 %). Provider liability climbed to $458.1 million, and accounts receivable to $444.0 million.
Management continues to highlight expansion into 16 markets, including recent entries into Indiana and Arizona, and underscores the shift toward higher-margin VBC contracts while maintaining a strong liquidity position.
FAQ
What is the current stock price of Privia Health Group (PRVA)?
What is the market cap of Privia Health Group (PRVA)?
